WSA
DPLO

Wall Street Associates’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Wall Street Associates’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-38,952
Closed -$1.74M – 358
2015
Q2 		$1.74M Buy
+38,952
New +$1.47M 0.16% 147

Other funds holding DPLO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wall Street Associates's DPLO Position: Q3 2015 in Review

Wall Street Associates sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q3 2015, closing a stake of 38,952 shares — an estimated $1.74M sold.

Wall Street Associates first reported a position in DPLO in Q2 2015 and held it in 1 quarter. The position peaked at $1.74M in Q2 2015. 130 funds tracked by Wall St. Rank hold DPLO as of Q3 2015.

  • Wall Street Associates reported no remaining DIPLOMAT PHARMACY, INC. position as of Q3 2015 after selling out during the quarter.
  • Wall Street Associates sold 38,952 DIPLOMAT PHARMACY, INC. shares in Q3 2015, an estimated $1.74M.
  • Wall Street Associates first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 1 quarter.
  • Wall Street Associates's DIPLOMAT PHARMACY, INC. position peaked at $1.74M in Q2 2015.
  • 130 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q3 2015.

Based on Wall Street Associates's 13F filing for Q3 2015, filed 12 Nov 2015.